Delivery Order SPE2DB24D2100-SPE2DB25FBFXL
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $27,314.50 for 100 tablets of Concerta ER 54 mg on August 15, 2025, with completion scheduled for August 18, 2025. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $47,631.00 for 100 tablets of Concerta ER 54 mg on September 3, 2025, with completion scheduled for September 4, 2025. This firm fixed price, competitively awarded contract (with no set-aside designation) represents a pharmaceutical supply delivery under the company's existing DLA contract vehicle. The medication will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The U.S. Department of Defense's Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $1,205.60 for Concerta ER Tablets 54mg, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price delivery order represents a single transaction under the company's broader relationship with the Defense Logistics Agency. The contract was executed on July 29, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $1,178.76 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 27 mg on June 27, 2025, with completion expected by June 30, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitive award to supply pharmaceutical products supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency (DLA) awarded a $5,978.22 delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 18 mg on July 31, 2025, with an ultimate completion date of August 1, 2025. This competitively awarded, non-set-aside contract employs firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply vehicle with DLA. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of...
- The Defense Logistics Agency awarded a delivery order valued at $6,446.16 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg, with an ultimate completion date of September 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA. This delivery order is...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 54 mg tablets (100-count units) valued at $2,021.76. This non-set-aside, competitively awarded contract operates under firm fixed pricing and is classified as a delivery order with an ultimate completion date of July 29, 2025. The order will be fulfilled from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $50,513.86 on September 19, 2025, for the supply of Concerta ER 54 mg tablets (100 count). The contract is a firm fixed-price delivery order with an ultimate completion date of September 22, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award was made through competitive procurement with no set-aside designation. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER 27 mg tablets (100 count) with a contract ceiling value of $11,539.08. This competitively awarded, non-set-aside delivery order carries a firm fixed price and is scheduled for completion by July 29, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform work at its corporate...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 100 tablets of Concerta 36mg, with a ceiling value of $3,715.96. This competitively awarded, non-set-aside contract utilizes firm fixed pricing and was delivered to the prime contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. The delivery order represents a single pharmaceutical procurement transaction under...
- SPE2DB24D2100Indefinite Delivery Contract
- SPE2DB24D2100-SPE2DB25FBFXLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,999.16 to AmerisourceBergen Drug Corp for 100 tablets of Concerta ER 54 mg, with an ultimate completion date of August 20, 2025. This competitively awarded, non-set-aside delivery order utilizes firm fixed pricing and represents a pharmaceutical supply transaction to support federal medical procurement needs. The contract work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. The parent IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including critical medications, vaccines, and specialized medical commodities. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen has demonstrated capability to fulfill federal medical supply requirements through open competition across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 8/19/25 |